Article
Antiferroptotic Drugs Reduce sFlt-1 Release and Placenta Damage in Preeclampsia
19 Aug 2025
Abstract excerpt
BACKGROUND: Preeclampsia is characterized by hypertension, proteinuria, and elevated antiangiogenic sFlt-1 (soluble fms-like tyrosine kinase-1) levels. Despite extensive research, mechanisms underlying sFlt-1 dysregulation remain unclear. This hypothesis-testing study investigated whether ferroptosis, a lipid peroxidation-driven cell death mechanism, contributes to preeclamptic placental pathogenesis and sFlt-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
